Skip to main content
LobbyMap

Novartis AG

Pharmaceutical & Health Products · Lobbying Client

B
Influence Score
62/100
High Influence
$12.2M
Total Lobby Spend
5
Policy Issues
5
Lobbyists
2
Revolving Door

Novartis AG reported $12.2 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 5 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Health IssuesPharmacyMedical/Disease ResearchTradeGovernment Issues

Government Entities Contacted

Food & Drug Administration
Dept of Justice
Office of Management & Budget
National Science Foundation
Dept of Commerce
Dept of Defense
Federal Energy Regulatory Commission

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2020 Jan-MarCovington & Burling LLP
TRDMEDPHA
3$561K
2020 Apr-JunK&L Gates LLP
GOVMEDPHA+2
1$516K
2020 Jul-SepAkin Gump LLP
GOVMEDHCR+2
3$788K
2020 Oct-DecBGR Group LLP
TRDPHAHCR+2
1$578K
2021 Jan-MarAkin Gump LLP
PHAGOVMED+2
1$745K
2021 Apr-JunCovington & Burling LLP
HCRMED
1$742K
2021 Jul-SepSquire Patton Boggs LLP
TRDHCRMED
4$636K
2021 Oct-DecSquire Patton Boggs LLP
TRDHCR
1$557K

Novartis AG Lobbying FAQ

Novartis AG has spent $12.2M on federal lobbying across 5 policy areas. This includes spending on registered lobbyists and direct government contacts.

Novartis AG lobbies on 5 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Trade. These disclosures are filed quarterly with the Senate Office of Public Records.

Novartis AG has an Influence Score of 62/100 (Grade B). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Novartis AG employs 5 registered lobbyists, of whom 2 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

Novartis AG has contacted 7 government entities as part of their lobbying activities, including Food & Drug Administration, Dept of Justice, Office of Management & Budget.

Explore Other Lobbying Organizations

US Chamber of Commerce

$434.1M lobbying spend · Trade Association · Influence Score A

National Association of Realtors

$358.3M lobbying spend · Real Estate · Influence Score B

Pharmaceutical Research & Manufacturers of America

$141.9M lobbying spend · Pharmaceutical & Health Products · Influence Score B

Blue Cross Blue Shield Association

$130.1M lobbying spend · Insurance · Influence Score B

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.